Myovant, Pfizer debut first branded campaign for prostate cancer med Orgovyx

Beth Snyder Bulik

Senior Editor

Myovant and Pfizer are pointing up the fact that prostate cancer treatment Orgovyx is a pill in the first direct-to-consumer campaign for the brand. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Myovant, Pfizer debut first branded campaign for prostate cancer med Orgovyx

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

My­ovant, Pfiz­er de­but first brand­ed cam­paign for prostate can­cer med Or­govyx

Senior Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Myovant, Pfizer debut first branded campaign for prostate cancer med Orgovyx